Blocking CB1 Receptors Makes Pesticide Poisoning Worse in Rats
A CB1 receptor antagonist increased the toxicity and lethality of organophosphorus pesticides in rats, providing evidence that the endocannabinoid system plays a protective role during pesticide poisoning.
Quick Facts
What This Study Found
Researchers tested whether blocking the endocannabinoid system would worsen poisoning from two organophosphorus pesticides (paraoxon and chlorpyrifos oxon) in rats.
The CB1 antagonist AM251, given 30 minutes after pesticide exposure, significantly increased involuntary movements at lower pesticide doses. With higher doses of paraoxon, AM251 increased lethality.
Chlorpyrifos oxon was more potent at inhibiting the enzymes that break down endocannabinoids (FAAH and MAGL), meaning it simultaneously blocks acetylcholinesterase (causing poisoning) and boosts endocannabinoid levels (providing some natural protection). Blocking CB1 receptors removed this protective mechanism.
Key Numbers
AM251 increased toxicity signs at lower doses of both pesticides; AM251 increased lethality with higher paraoxon dose; chlorpyrifos oxon was 8-fold more potent at inhibiting FAAH and 19-fold more potent at inhibiting MAGL than paraoxon
How They Did This
Rat study comparing two organophosphorus compounds at two doses each, with and without the CB1 antagonist AM251. Measured toxicity signs over 4 hours, lethality, and enzyme inhibition (AChE, FAAH, MAGL) in hippocampal tissue.
Why This Research Matters
This study reveals that the endocannabinoid system functions as a natural protective mechanism during pesticide poisoning. Understanding this could inform treatment strategies for organophosphorus exposure, which affects agricultural workers and remains a chemical weapons concern.
The Bigger Picture
The endocannabinoid system appears to serve as a natural brake on the cholinergic crisis that characterizes organophosphorus poisoning. This has implications for both pesticide exposure treatment and for understanding how the endocannabinoid system protects the brain from excitotoxicity.
What This Study Doesn't Tell Us
Animal study with limited sample sizes. Used a single dose of AM251. The protective role of endocannabinoids may differ between acute and chronic exposure. Translation to human pesticide poisoning treatment requires further study.
Questions This Raises
- ?Could cannabinoid agonists be used as part of organophosphorus poisoning treatment?
- ?Does chronic pesticide exposure alter endocannabinoid system function?
- ?Are people who use CB1 antagonists (or inverse agonists) at greater risk from pesticide exposure?
Trust & Context
- Key Stat:
- CB1 antagonist increased lethality from pesticide poisoning
- Evidence Grade:
- Controlled animal study demonstrating a clear mechanistic relationship, but limited to rats and specific compounds.
- Study Age:
- Published in 2015. Research on endocannabinoid neuroprotection has continued to expand.
- Original Title:
- The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.
- Published In:
- Neurotoxicology, 46, 12-8 (2015)
- Authors:
- Liu, Jing, Pope, Carey
- Database ID:
- RTHC-01001
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How does the endocannabinoid system protect against pesticide poisoning?
Organophosphorus pesticides cause poisoning by allowing acetylcholine to build up. The endocannabinoid system reduces neurotransmitter release, including acetylcholine, which helps counteract the toxic buildup. Blocking CB1 receptors removes this protective brake.
Does this apply to cannabis users?
The study used a CB1 receptor antagonist, not cannabis. The findings suggest the endocannabinoid system (which works with or without cannabis use) provides natural protection. Whether cannabis use itself would affect pesticide toxicity was not tested.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-01001APA
Liu, Jing; Pope, Carey. (2015). The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.. Neurotoxicology, 46, 12-8. https://doi.org/10.1016/j.neuro.2014.11.001
MLA
Liu, Jing, et al. "The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.." Neurotoxicology, 2015. https://doi.org/10.1016/j.neuro.2014.11.001
RethinkTHC
RethinkTHC Research Database. "The cannabinoid receptor antagonist AM251 increases paraoxon..." RTHC-01001. Retrieved from https://rethinkthc.com/research/liu-2015-the-cannabinoid-receptor-antagonist
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.